Trial Details

UNKNOWN
Basic Information
Clinical ID c373
Identifier NCT03375424
Trial Title Vedolizumab Study With Inflammatory Bowel Disease Patients in Germany
Trial URL Visit Original Page
Study Information
Study Results

NO

Conditions Inflammatory Bowel Diseases|Treatment
Interventions BIOLOGICAL: vedolizumab
Participant Information
Sponsor Ced Service GmbH
City Minden
Country/Region Germany
Enrollment Criteria
Sex Requirement ALL
Age Requirement ADULT, OLDER_ADULT
Study Design
Study Type OBSERVATIONAL
Phase -
Time Information
Start Date 2017-10-02
Primary Completion Date 2019-04-30
Completion Date 2024-04-30